Skip to content

Price / sales at other companies

Schneider National logo
Schneider NationalSNDR
0.8×+0.1×
Federated Hermes logo
Federated HermesFHI
2.3×+0.3×
EPR Properties logo
EPR PropertiesEPR
5.3×-0.4×
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
4.2×+2.5×
Silgan Holdings logo
Silgan HoldingsSLGN
0.6×-0.3×
CleanSpark logo
CleanSparkCLSK
5.3×-0.9×

Other financials

Income statement

See full
Revenue$12.5B+8.7%
Gross profit$977.0M+1.8%
Operating income$403.0M+13.5%
Net income$20.0M-76.2%

Balance sheet

See full
Cash & equivalents$172.0M-59.9%
Total debt$2.5B-74.0%
Total equity$14.1B-4.1%
Total assets$32.8B+16.0%

Cash flow

See full
Operating cash flow$418.0M-34.5%
CapEx$130.0M-7.1%
Free cash flow$288.0M-42.2%

Valuation

See full
Market cap$4.6B+13.8%
Enterprise value$6.89B-46.5%
P/E23.6×-4.3×

Profitability

See full
Gross margin8.5%+0.8pp
Operating margin3.3%+1.5pp
Net margin0.4%+0.1pp
FCF margin4.6%-0.1pp

Returns & leverage

See full
Return on equity1.3%+0.2pp
Debt / equity0.8×+0.1×
Current ratio0.9×-0.1×

Where this comes from

Calculated from Plains GP Holdings, L.P.’s reported figures.

Based on the most recent quarter.

The official record: Plains GP Holdings, L.P.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Plains GP Holdings, L.P.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Plains GP Holdings, L.P.'s price / sales?
Plains GP Holdings, L.P. (PAGP) reported price / sales of 0.1× in Q1 2026.
How has Plains GP Holdings, L.P.'s price / sales changed year-over-year?
Plains GP Holdings, L.P.'s price / sales increased by 22.5% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Plains GP Holdings, L.P.'s price / sales?
Over 5 years (2020 to 2025), Plains GP Holdings, L.P.'s price / sales has grown at a 4.0% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.